phenylephrine hydrochloride 0.667 MG/ML / thonzylamine hydrochloride 3.33 MG/ML Oral Solution [Nasopen PE]

RxCUI: 1360733
RxNorm name: phenylephrine hydrochloride 0.667 MG/ML / thonzylamine hydrochloride 3.33 MG/ML Oral Solution [Nasopen PE]
Display name: NASOPEN PE (Oral Liquid)
Full name: phenylephrine hydrochloride 0.667 MG/ML / thonzylamine hydrochloride 3.33 MG/ML Oral Solution [Nasopen PE]
Term type: SBD
Status: Active
Strength: 10-50 mg/15ml
Dose form: Sol
Route: Oral Liquid
Updated: 2026-07-24 06:52:36

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 012013
Active start: 012013
Multiple ingredient: YES
Branded: YES

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
thonzylamine hydrochloride	3.33 MG / 1 ML	thonzylamine	thonzylamine hydrochloride
phenylephrine hydrochloride	0.667 MG / 1 ML	phenylephrine	phenylephrine hydrochloride

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Oral Solution	316968

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
thonzylamine	1360721
phenylephrine	8163

Source Vocabulary Codes#

Code type, Value, Category table
Code type	Value	Category
PRESCRIBABLE	Y	ATTRIBUTES
RXNAV_STR	Nasopen PE (phenylephrine HCl 10 MG / thonzylamine HCl 50 MG) per 15 ML Oral Solution	NAMES
RxNorm Name	phenylephrine hydrochloride 0.667 MG/ML / thonzylamine hydrochloride 3.33 MG/ML Oral Solution [Nasopen PE]	NAMES
RxNorm Synonym	Nasopen PE (phenylephrine HCl 10 MG / thonzylamine HCl 50 MG) per 15 ML Oral Solution	NAMES
TTY	SBD	ATTRIBUTES
RxCUI	1360733	CODES
MMSL_CODE	BD28617	CODES

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11	Source	Active
58809072904	rxnav_ndcs	yes

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	C01CA	Adrenergic and dopaminergic agents	ATC1-4		phenylephrine
ATC	R01AC	Antiallergic agents, excl. corticosteroids	ATC1-4		thonzylamine
ATC	D04AA	Antihistamines for topical use	ATC1-4		thonzylamine
ATC	C05AX	Other agents for treatment of hemorrhoids and anal fissures for topical use	ATC1-4		phenylephrine
ATC	R06AC	Substituted ethylene diamines	ATC1-4		thonzylamine
ATC	R01BA	Sympathomimetics	ATC1-4		phenylephrine
ATC	S01FB	Sympathomimetics excl. antiglaucoma preparations	ATC1-4		phenylephrine
ATC	S01GA	Sympathomimetics used as decongestants	ATC1-4		phenylephrine
ATC	R01AB	Sympathomimetics, combinations excl. corticosteroids	ATC1-4		phenylephrine
ATC	R01AA	Sympathomimetics, plain	ATC1-4		phenylephrine
FDASPL	N0000186105	alpha-1 Adrenergic Agonist	EPC	has_epc	phenylephrine
MEDRT	D010656	Phenylephrine	CHEM	has_ingredient	phenylephrine hydrochloride
MEDRT	D010656	Phenylephrine	CHEM	has_ingredient	phenylephrine
MEDRT	D011743	Pyrimidines	CHEM	has_ingredient	thonzylamine
MEDRT	D011743	Pyrimidines	CHEM	has_ingredient	thonzylamine hydrochloride
MEDRT	D013447	Sulfites	CHEM	ci_chemclass	phenylephrine
MEDRT	D013447	Sulfites	CHEM	ci_chemclass	phenylephrine hydrochloride
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	phenylephrine hydrochloride
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	phenylephrine
MEDRT	D005401	Fissure in Ano	DISEASE	may_treat	phenylephrine hydrochloride
MEDRT	D005401	Fissure in Ano	DISEASE	may_treat	phenylephrine
MEDRT	D005902	Glaucoma, Open-Angle	DISEASE	may_treat	phenylephrine hydrochloride
MEDRT	D005902	Glaucoma, Open-Angle	DISEASE	may_treat	phenylephrine
MEDRT	D006484	Hemorrhoids	DISEASE	may_treat	phenylephrine
MEDRT	D006484	Hemorrhoids	DISEASE	may_treat	phenylephrine hydrochloride
MEDRT	D006973	Hypertension	DISEASE	ci_with	phenylephrine
MEDRT	D006973	Hypertension	DISEASE	ci_with	phenylephrine hydrochloride
MEDRT	D007022	Hypotension	DISEASE	may_treat	phenylephrine
MEDRT	D007022	Hypotension	DISEASE	may_treat	phenylephrine hydrochloride
MEDRT	D015878	Mydriasis	DISEASE	induces	phenylephrine
MEDRT	D015878	Mydriasis	DISEASE	induces	phenylephrine hydrochloride
MEDRT	D011538	Pruritus Ani	DISEASE	may_treat	phenylephrine hydrochloride
MEDRT	D011538	Pruritus Ani	DISEASE	may_treat	phenylephrine
MEDRT	D012223	Rhinitis, Vasomotor	DISEASE	may_treat	phenylephrine hydrochloride
MEDRT	D012223	Rhinitis, Vasomotor	DISEASE	may_treat	phenylephrine
MEDRT	D012772	Shock, Septic	DISEASE	may_treat	phenylephrine hydrochloride
MEDRT	D012772	Shock, Septic	DISEASE	may_treat	phenylephrine
MEDRT	D013617	Tachycardia, Supraventricular	DISEASE	may_treat	phenylephrine hydrochloride
MEDRT	D013617	Tachycardia, Supraventricular	DISEASE	may_treat	phenylephrine
MEDRT	D017180	Tachycardia, Ventricular	DISEASE	ci_with	phenylephrine
MEDRT	D017180	Tachycardia, Ventricular	DISEASE	ci_with	phenylephrine hydrochloride
MEDRT	N0000000209	Adrenergic alpha-Agonists	MOA	has_moa	phenylephrine
MEDRT	N0000000209	Adrenergic alpha-Agonists	MOA	has_moa	phenylephrine hydrochloride
MEDRT	N0000008371	Conjunctival Arterial Vasoconstriction	PE	has_pe	phenylephrine
MEDRT	N0000008371	Conjunctival Arterial Vasoconstriction	PE	has_pe	phenylephrine hydrochloride
MEDRT	N0000008896	Decreased Nasal and Sinus Secretions	PE	has_pe	phenylephrine hydrochloride
MEDRT	N0000008896	Decreased Nasal and Sinus Secretions	PE	has_pe	phenylephrine

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Nasopen PE	rxnav_allrelated
DF	DF	Oral Solution	rxnav_allrelated
DFG	DFG	Oral Liquid Product	rxnav_allrelated
DFG	DFG	Oral Product	rxnav_allrelated
IN	IN	phenylephrine	rxnav_allrelated
IN	IN	thonzylamine	rxnav_allrelated
MIN	MIN	phenylephrine / thonzylamine	rxnav_allrelated
PIN	PIN	phenylephrine hydrochloride	rxnav_allrelated
PIN	PIN	thonzylamine hydrochloride	rxnav_allrelated
SBD	SBD	phenylephrine hydrochloride 0.667 MG/ML / thonzylamine hydrochloride 3.33 MG/ML Oral Solution [Nasopen PE]	rxnav_allrelated
SBDC	SBDC	phenylephrine hydrochloride 0.667 MG/ML / thonzylamine hydrochloride 3.33 MG/ML [Nasopen PE]	rxnav_allrelated
SBDF	SBDF	phenylephrine / thonzylamine Oral Solution [Nasopen PE]	rxnav_allrelated
SBDFP	SBDFP	phenylephrine hydrochloride / thonzylamine hydrochloride Oral Solution [Nasopen PE]	rxnav_allrelated
SBDG	SBDG	Nasopen PE Oral Liquid Product	rxnav_allrelated
SBDG	SBDG	Nasopen PE Oral Product	rxnav_allrelated
SCD	SCD	phenylephrine hydrochloride 0.667 MG/ML / thonzylamine hydrochloride 3.33 MG/ML Oral Solution	rxnav_allrelated
SCDC	SCDC	phenylephrine hydrochloride 0.667 MG/ML	rxnav_allrelated
SCDC	SCDC	thonzylamine hydrochloride 3.33 MG/ML	rxnav_allrelated
SCDF	SCDF	phenylephrine / thonzylamine Oral Solution	rxnav_allrelated
SCDFP	SCDFP	phenylephrine hydrochloride / thonzylamine hydrochloride Oral Solution	rxnav_allrelated
SCDG	SCDG	phenylephrine / thonzylamine Oral Liquid Product	rxnav_allrelated
SCDG	SCDG	phenylephrine / thonzylamine Oral Product	rxnav_allrelated
SCDGP	SCDGP	phenylephrine hydrochloride / thonzylamine hydrochloride Oral Liquid Product	rxnav_allrelated
SCDGP	SCDGP	phenylephrine hydrochloride / thonzylamine hydrochloride Oral Product	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	0.667 MG/ML / 3.33 MG/ML
ATTRIBUTES	GENERAL_CARDINALITY	MULTI
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	PRESCRIBABLE	Y
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
ATTRIBUTES	SCHEDULE	0
ATTRIBUTES	TTY	SBD
CODES	MMSL_CODE	BD28617
CODES	RxCUI	1360733
NAMES	Prescribable Synonym	NASOPEN PE 10 MG / 50 MG in 15 mL Oral Solution
NAMES	RXNAV_STR	Nasopen PE (phenylephrine HCl 10 MG / thonzylamine HCl 50 MG) per 15 ML Oral Solution
NAMES	RxNorm Name	phenylephrine hydrochloride 0.667 MG/ML / thonzylamine hydrochloride 3.33 MG/ML Oral Solution [Nasopen PE]
NAMES	RxNorm Synonym	Nasopen PE (phenylephrine HCl 10 MG / thonzylamine HCl 50 MG) per 15 ML Oral Solution
SOURCES	Source	Gold Standard Alchemy
SOURCES	Source	Multum MediSource Lexicon

phenylephrine hydrochloride 0.667 MG/ML / thonzylamine hydrochloride 3.33 MG/ML Oral Solution [Nasopen PE]

RxNorm Status History#

Ingredients And Strength#

Dose Form Concepts#

Derived Ingredient Concepts#

Source Vocabulary Codes#

RxNav Current And Historical NDCs#

Drug Classes#

Related Concepts#

Properties#